14.6 C
New York
Saturday, November 21, 2026
- Advertisement -spot_img

TAG

Infilbray

Venglustat Wins FDA Approval for Rare Brain Disorder

The FDA approved Sanofi's venglustat, sold as Infilbray, the first drug for the brain and nerve symptoms of type 3 Gaucher disease in adults and children.

Latest news

- Advertisement -spot_img